According to the Pharma Disclosure resources, “[t]he move to introduce the new transparency code in Europe mirrors the introduction in the US of ‘Physician Financial Transparency Reports’ under the Sunshine Act.” Unlike the Sunshine Act, however, EFPIA covers 33 separate countries. EFPIA st...
.This is most obvious in Western European countries,but it is also the 56、case in the EU4+UK and in the Nordics.Central and Eastern European(CEE)and Southern European countries,although experiencing the longest time until availability on average,have not experienced as significant an increase ...
In order to support countries creating or further developing their PV systems, especially where infrastructure and resources are limited, the European Federation of Pharmaceutical Industries and Associations (EFPIA) International Pharmacovigilance Group (IPVG) has developed consensus recommendations consistent ...
BMS will only publish the individual recipient details where consent has been positively given (for those countries where consent is required). If an HCP or HCO (in those countries where consent is required) has not given consent or has not responded to the consent request, they will be ...
the rate of availability remains consistently lower and has fallen.15 The European average was calculated using all 36 countries included in the W.A.I.T.data except Malta.These countries are then grouped by region to generate the region-specific evidence.The root causes of unavailability of ...
BMS will only publish the individual recipient details where consent has been positively given (for those countries where consent is required). If an HCP or HCO (in those countries where consent is required) has not given consent or has not responded to the consent request, they will be ...